Logo
x

Search category

Subscribe Now

EC

The EC Opens Antitrust Investigation Against Vifor Pharma’s Anti-Competitive Disparagement for Iron Deficiency Treatment

The EC Opens Antitrust Investigation Against Vifor Pharma’s Anti-Competitive Disparagement for Iron Deficiency Treatment

  • June 21, 2022
GSK's Nucala (mepolizumab) Receives the EC's Approval for the Treatment of Eosinophil-Driven Diseases

GSK's Nucala (mepolizumab) Receives the EC's Approval for the Treatment of Eosinophil-Driven Diseases

  • November 18, 2021
Insights+: The US FDA New Drug Approvals in October 2021

Insights+: The US FDA New Drug Approvals in October 2021

  • November 18, 2021
Biogen's Vumerity (diroximel fumarate) Receives the EC's Approval for the Treatment of Relapsing-Remitting Multiple Sclerosis

Biogen's Vumerity (diroximel fumarate) Receives the EC's Approval for the Treatment of Relapsing-Remitting Multiple Sclerosis

  • November 17, 2021
AstraZeneca and Moderna Present Results of AZD8601 in P-IIa EPICCURE Trial for the Treatment of Heart Failure at AHA 2021

AstraZeneca and Moderna Present Results of AZD8601 in P-IIa EPICCURE Trial for the Treatment of Heart Failure at AHA 2021

  • November 16, 2021
AbbVie's Rinvoq (upadacitinib) Receives EC's Approval for the Treatment of Moderate to Severe Atopic Dermatitis

AbbVie's Rinvoq (upadacitinib) Receives EC's Approval for the Treatment of Moderate to Severe Atopic Dermatitis

  • August 25, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.